The role of MDM2 in the proliferative activity of ameloblastoma

Oral Oncology

Volumn 38, Issue 2, 2002, Pages 153-157

  Sandra, F ^a   Nakamura, N ^a   Kanematsu, T ^a   Hirata, M ^a   Ohishi, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Ameloblastoma; MDM2; Odontogenic tumor; p53

Indexed keywords

MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P53;

AMELOBLASTOMA; ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION;

AMELOBLASTOMA; BLOTTING, WESTERN; CELL DIVISION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; JAW NEOPLASMS; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036180587     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(01)00036-7     Document Type: Article

References (26)

1. Maxillary ameloblastoma with orbital invasion. A clinicopathologic study
2. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma
3. Two relatively distinct patterns of ameloblastoma: An anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (center)
4. P53, the cellular gatekeeper for growth and division
5. Regulation of p53 stability
6. Regulation of p53 in response to DNA damage
7. Exploiting the p53 pathway for cancer diagnosis and therapy
8. MDM2-master regulator of the p53 tumor suppressor protein
9. MDM2 function
10. MDM2: The ups and downs
11. Functions of the MDM2 oncoprotein
12. The MDM2 proto-oncogene
13. MDM2: Keeping p53 under control
14. MDM2: A bridge over the two tumour suppressors, p53 and Rb
15. MDM2 oncogene as a novel target for human cancer therapy
16. P53 in tumour pathology: Can we trust immunocytochemistry?
17. P53 immunohistochemistry: A word of caution
18. P53 in tumour pathology: Can we trust immunohistochemistry? - Revisited!
19. MDM2/p53 co-expression in oral premalignant and malignant lesions: Potential prognostic implications
20. p53 and MDM2 expression in oral squamous cell carcinoma
21. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation
22. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas
23. p53 and MDM2 expression in odontogenic cysts and tumours
24. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study